CanSino Biologics, Inc. (CASBF)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Jan 20, 2025

$3.62

P/E Ratio

N/A

Market Cap

$1.18B

Loading...
Description

CanSino Biologics, Inc. engages in the research and development, manufacturing, and sale of vaccines. It offers shingles, meningitis, polio, adenovirus, and tuberculosis vaccines. The company was founded by Xuan Liu, Xue Feng Yu, Tao Zhu, Dong Xu Qiu and Hui Hua Mao on January 13, 2009 and is headquartered in Tianjin, China.

Metrics

Overview

  • HQTianjin, TI
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerCASBF
  • Price$3.623046+0.02%

Trading Information

  • Market cap$1.18B
  • Float26.85%
  • Average Daily Volume (1m)887,473
  • Average Daily Volume (3m)1,424,446
  • EPS-$3.15

Company

  • Revenue$802.00M
  • Rev growth (1yr)77.66%
  • Net income$3.23M
  • Gross margin78.99%
  • EBITDA marginN/A
  • EBITDAN/A
  • EV$5.74B
  • EV/Revenue7.15
  • P/EN/A
  • P/S10.55
  • P/B1.28
Documents